Crescent Pharma Limited has issued a recall of one batch of Ramipril 10mg capsules. The recall is being carried out as a precautionary measure following the identification of a potential error at the manufacturing site. The Medicines and Healthcare products Regulatory Agency (MHRA) has been notified of the recall.
Actualizaciones regulatorias23 ago 2026•1 min de lectura
Crescent Pharma Recalls Ramipril 10mg Capsules Batch
Crescent Pharma Limited is recalling a batch of Ramipril 10mg capsules as a precaution due to a possible manufacturing error.
Recopilado por el equipo de PharmaCountry · Fuente: MHRA
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración